Zobrazeno 1 - 10
of 14
pro vyhledávání: '"I-Chen Tai"'
Autor:
Shu-Hsing Cheng, Chia En Lien, Szu-Min Hsieh, Chien-Yu Cheng, Wang-Da Liu, Ching-Lung Lo, Wen-Chien Ko, Yen-Hsu Chen, Ching-Tai Huang, Hsiao-Ting Chang, Shinn-Jang Hwang, Ning-Chi Wang, Ming-Che Liu, Yu-Lin Lee, I-Chen Tai, Josue Antonio Garcia Estrada, Tzou-Yien Lin, Wen-Sen Lee
Publikováno v:
Vaccines, Vol 11, Iss 1, p 18 (2022)
Background: This study aimed to assess the safety and immunogenicity of MVC-COV1901, a recombinant COVID-19 protein vaccine, containing S-2P protein adjuvanted with CpG 1018 and aluminum hydroxide, for people living with HIV (PWH). Methods: A total o
Externí odkaz:
https://doaj.org/article/b2fd1c6f7c37476097e77a8ce1c04555
Autor:
Szu-Min Hsieh, Wang-Da Liu, Yu-Shan Huang, Yi-Jiun Lin, Erh-Fang Hsieh, Wei-Cheng Lian, Charles Chen, Robert Janssen, Shin-Ru Shih, Chung-Guei Huang, I-Chen Tai, Shan-Chwen Chang
Publikováno v:
EClinicalMedicine, Vol 38, Iss , Pp 100989- (2021)
Background: This was a phase 1, dose-escalation open-label trial to evaluate the safety and immunogenicity of MVCCOV1901, a SARS-CoV-2 S-2P protein vaccine adjuvanted with aluminum hydroxide and CpG 1018. Methods: Between September 28 and November
Externí odkaz:
https://doaj.org/article/a9515141209b4cf29537807b566caec5
Autor:
I-Chen Tai, 戴怡真
國民教育研究所（83~93.7.31)
92
The purpose of this study was to investigate opinions of the whole and each aspect of applying knowledge management to promote classroom management specific actions, to explore separately the different
92
The purpose of this study was to investigate opinions of the whole and each aspect of applying knowledge management to promote classroom management specific actions, to explore separately the different
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/93552925647623660851
Autor:
Trong Toan, Nguyen, Cheng-Hsun, Chiu, Chien-Yu, Lin, Nan-Chang, Chiu, Po-Yen, Chen, Thi Tuong Vy, Le, Dang Ngan, Le, An Han, Duong, Van Luan, Nguyen, Thi Nguyet, Huynh, Huu Khanh, Truong, Trong Lan, Phan, Thi Thanh Thao, Nguyen, Shin-Ru, Shih, Chung-Guei, Huang, Yi-Jen, Weng, Erh-Fang, Hsieh, Stanley, Chang, Charles, Chen, I-Chen, Tai, Li-Min, Huang
Publikováno v:
The Lancet. 399:1708-1717
Children are susceptible to severe or fatal enterovirus 71 (EV71) infections. We aimed to evaluate the efficacy, safety, and immunogenicity of EV71vac, an aluminium phosphate-adjuvanted inactivated EV71 vaccine in children aged 2-71 months.We did a r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::602bffcf718ce8439c33a42a510be43c
https://doi.org/10.1016/s0140-6736(22)00313-0
https://doi.org/10.1016/s0140-6736(22)00313-0
Autor:
Toan Trong Nguyen, Cheng-Hsun Chiu, Chien-Yu Lin, Nan-Chang Chiu, Po-Yen Chen, Thi Tuong Vy Le, Dang Ngan Le, An Han Duong, Van Luan Nguyen, Thi Nguyet Huyn, Huu Khanh Troung, Trong Lan Phan, Thi Thanh Thao Nguyen, Shin-Ru Shih, Chung-Guei Huang, Yi-Jen Wen, Erh-Fang Hsieh, Stanley Chang, Charles Chen, I-Chen Tai, Li-Min Huang
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47aecc931808a8d9939151042c89d69a
https://doi.org/10.2139/ssrn.4000536
https://doi.org/10.2139/ssrn.4000536
A post-hoc analysis of the phase 2 data was performed for the SARS-COV-2 subunit protein vaccine MVC-COV1901. Anti-spike IgG, neutralization assays with live virus and pseudovirus were used to demonstrate age-dependent vaccine-induced antibody respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e89a17af675983673007d62d3f8d2d86
https://doi.org/10.1101/2021.12.12.21267573
https://doi.org/10.1101/2021.12.12.21267573
Autor:
Shu-Hsing Cheng, Chia En Lien, Szu-Min Hsieh, Chien-Yu Cheng, Wang-Da Liu, Ching-Lung Lo, Wen-Chien Ko, Yen-Hsu Chen, Ching-Tai Huang, Hsiao-Ting Chang, Shinn-Jang Hwang, Ning-Chi Wang, Ming-Che Liu, Yu-Lin Lee, I-Chen Tai, Josue Antonio Garcia Estrada, Tzou-Yien Lin, Wen-Sen Lee
ObjectivesTo provide data on the immune response to COVID-19 vaccines in people living with HIV (PWH), MVC-COV1901, a recombinant protein vaccine containing S-2P protein adjuvanted with CpG 1018 and aluminium hydroxide, was assessed.MethodsA total of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46a8dfad6d5d57c371bbea1f3199ea85
https://doi.org/10.1101/2021.12.08.21267439
https://doi.org/10.1101/2021.12.08.21267439
Autor:
Hsieh Szu-Min, Ming-Che Liu, Yen-Hsu Chen, Wen-Sen Lee, Shinn-Jang Hwang, Shu-Hsing Cheng, Wen-Chien Ko, Kao-Pin Hwang, Ning-Chi Wang, Yu-Lin Lee, Yi-Ling Lin, Shin-Ru Shih, Chung-Guei Huang, Chun-Che Liao, Jian-Jong Liang, Chih-Shin Chang, Charles Chen, Chia En Lien, I-Chen Tai, Tzou-Yien Lin
SummaryBackgroundWe have assessed the safety and immunogenicity of the COVID-19 vaccine MVC-COV1901, a recombinant protein vaccine containing prefusion-stabilized spike protein S-2P adjuvanted with CpG 1018 and aluminium hydroxide.MethodsThis is a ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6bc5fd69712afa5ff41d0ce044db6d7
https://doi.org/10.1101/2021.08.05.21261532
https://doi.org/10.1101/2021.08.05.21261532
Autor:
Robert Janssen, Yi-Jiun Lin, I-Chen Tai, Yu-Shan Huang, Wei-Cheng Lian, Shan-Chwen Chang, Charles Chen, Wang-Da Liu, Szu-Min Hsieh, Erh-Fang Hsieh, Chung-Guei Huang, Shin-Ru Shih
Publikováno v:
EClinicalMedicine, Vol 38, Iss, Pp 100989-(2021)
EClinicalMedicine
EClinicalMedicine
Background: This was a phase 1, dose-escalation open-label trial to evaluate the safety and immunogenicity of MVC-COV1901, a SARS-CoV-2 S-2P protein vaccine adjuvanted with aluminum hydroxide and CpG 1018. Methods: Between September 28 and November 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccf7293486095fb8d876a6e17d17513a
http://www.sciencedirect.com/science/article/pii/S2589537021002698
http://www.sciencedirect.com/science/article/pii/S2589537021002698
Autor:
Yu-Shan Huang, Yi-Jiun Lin, I-Chen Tai, Wei-Cheng Lian, Szu-Min Hsieh, Shan-Chwen Chang, Wang-Da Liu, Charles Chen, Erh-Fang Hsieh
DesignThis is a phase 1, dose-escalation open-label trial to evaluate the safety and immunogenicity of MVC-COV1901, a recombinant stabilized prefusion SARS-CoV-2 spike (S-2P) protein vaccine with adjuvant of aluminum hydroxide and CpG 1018.MethodsWe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e76906dc3685b77287f3092eb978d205
https://doi.org/10.1101/2021.03.31.21254668
https://doi.org/10.1101/2021.03.31.21254668